{"id":"W4389030754","doi":"10.1093/ofid/ofad500.1422","title":"1587. SOLAR 12-Month North American Results: Randomized Switch Trial of CAB+RPV LA vs. Oral BIC/FTC/TAF","year":2023,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Emtricitabine; Tolerability; Tenofovir alafenamide; Clinical endpoint; Population; Regimen; Rilpivirine; Internal medicine; Randomized controlled trial; Adverse effect; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy; Family medicine; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001560206,0.001011516,0.001760862,0.0003158823,0.000590597,0.0010001,0.0006981223,0.001579929,0.01601913],"category_scores_gemma":[0.001193064,0.0005083927,0.001494408,0.0003156574,0.0009072263,0.0007906488,0.0003067018,0.00243803,0.001767329],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006508407,"about_ca_system_score_gemma":0.001373045,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002637739,"about_ca_topic_score_gemma":0.006584277,"domain_scores_codex":[0.9992487,0.0004826489,0.00003196605,0.0001126023,0.00004006861,0.00008403898],"domain_scores_gemma":[0.9991534,0.000194277,0.0001742574,0.00005775853,0.00008577237,0.0003346069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9808965,0.003986587,0.0007111579,0.0002624091,0.0005993151,0.00002527293,0.00003411154,0.0001573936,0.001182313,0.0001104614,0.00190846,0.01012608],"study_design_scores_gemma":[0.9408186,0.05317408,0.003402223,0.00004331693,0.0005217628,0.00002483168,0.00004298951,0.0004328553,0.0001912766,0.0001780021,0.001158645,0.00001147557],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9801313,0.004100205,0.0003656858,0.001739501,0.0007606182,0.003305652,0.002289485,0.0001899655,0.007117422],"genre_scores_gemma":[0.9836707,0.001279788,0.0009615599,0.002331861,0.0005331794,0.002761446,0.00146669,0.0000293015,0.006965424],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9973623,"threshold_uncertainty_score":0.05358934,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01326574133440445,"score_gpt":0.2927594698144864,"score_spread":0.2794937284800819,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}